• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞因子与癌症

Cytokines and cancer.

作者信息

Tartour E, Fridman W H

机构信息

INSERM U255 et Laboratoire d'Immunologie Clinique, Institut Curie, Paris, France.

出版信息

Int Rev Immunol. 1998;16(5-6):683-704. doi: 10.3109/08830189809043014.

DOI:10.3109/08830189809043014
PMID:9646182
Abstract

The relationships between cytokines and cancer are multiple and bidirectional. On the one hand, cytokines may directly influence carcinogenesis and metastasis by modifying the tumor phenotype. On the other hand, during tumor progression, modifications of the cytokine expression in the tumor environment may be induced by the tumor cells, leading to a state of immunosuppression reflected by low cytokine expression in tumor stroma. Cytokines also play a role by stimulating the host immune system to generate anti-tumor specific responses. Finally, the use of cytokines as anti-tumor agents has led to objective clinical responses in about 15-25% of patients with metastatic melanoma or renal cell carcinoma, which presents the basis for the development of promising immunotherapeutic approaches for cancer therapy.

摘要

细胞因子与癌症之间的关系是多方面且双向的。一方面,细胞因子可通过改变肿瘤表型直接影响致癌作用和转移。另一方面,在肿瘤进展过程中,肿瘤细胞可能诱导肿瘤环境中细胞因子表达的改变,导致肿瘤基质中细胞因子低表达所反映的免疫抑制状态。细胞因子还通过刺激宿主免疫系统产生抗肿瘤特异性反应发挥作用。最后,将细胞因子用作抗肿瘤药物已在约15%至25%的转移性黑色素瘤或肾细胞癌患者中产生了客观的临床反应,这为开发有前景的癌症免疫治疗方法奠定了基础。

相似文献

1
Cytokines and cancer.细胞因子与癌症
Int Rev Immunol. 1998;16(5-6):683-704. doi: 10.3109/08830189809043014.
2
Cytokine-induced tumor immunogenicity: from exogenous cytokines to gene therapy.细胞因子诱导的肿瘤免疫原性:从外源性细胞因子到基因治疗
J Immunother Emphasis Tumor Immunol. 1993 Nov;14(4):253-7. doi: 10.1097/00002371-199311000-00001.
3
A stressful microenvironment: opposing effects of the endoplasmic reticulum stress response in the suppression and enhancement of adaptive tumor immunity.应激微环境:内质网应激反应在抑制和增强适应性肿瘤免疫中的相反作用。
Int Rev Immunol. 2015 Mar;34(2):104-22. doi: 10.3109/08830185.2015.1018415. Epub 2015 Mar 16.
4
Ascophyllan functions as an adjuvant to promote anti-cancer effect by dendritic cell activation.岩藻聚糖硫酸酯作为一种佐剂,通过激活树突状细胞来促进抗癌效果。
Oncotarget. 2016 Apr 12;7(15):19284-98. doi: 10.18632/oncotarget.8200.
5
Delivery of TLR7 agonist to monocytes and dendritic cells by DCIR targeted liposomes induces robust production of anti-cancer cytokines.通过DCIR靶向脂质体将TLR7激动剂递送至单核细胞和树突状细胞可诱导抗癌细胞因子的大量产生。
Acta Biomater. 2017 Apr 15;53:367-377. doi: 10.1016/j.actbio.2017.01.072. Epub 2017 Jan 30.
6
Cytokine regulation networks in the cancer microenvironment.癌症微环境中的细胞因子调控网络。
Front Biosci. 2008 May 1;13:6255-68. doi: 10.2741/3152.
7
Considerations for the use of cytokine-secreting tumor cell preparations for cancer treatment.关于使用分泌细胞因子的肿瘤细胞制剂进行癌症治疗的考量。
Cancer Invest. 1995;13(2):193-201. doi: 10.3109/07357909509011690.
8
Reversal of tumor-induced immunosuppression: a new approach to cancer therapy.肿瘤诱导的免疫抑制的逆转:癌症治疗的新方法。
J Immunother. 1997 May;20(3):165-77.
9
The promising alliance of anti-cancer electrochemotherapy with immunotherapy.抗癌电化学疗法与免疫疗法的前景广阔的联合应用。
Cancer Metastasis Rev. 2016 Jun;35(2):165-77. doi: 10.1007/s10555-016-9615-3.
10
Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.用于实体瘤免疫治疗的细胞因子、趋化因子和共刺激融合蛋白。
Handb Exp Pharmacol. 2008(181):291-328. doi: 10.1007/978-3-540-73259-4_13.

引用本文的文献

1
Extranodal lymphoma: pathogenesis, diagnosis and treatment.结外淋巴瘤:发病机制、诊断与治疗
Mol Biomed. 2023 Sep 18;4(1):29. doi: 10.1186/s43556-023-00141-3.
2
Clostridial spores for cancer therapy: targeting solid tumour microenvironment.用于癌症治疗的梭菌孢子:靶向实体瘤微环境
J Toxicol. 2012;2012:862764. doi: 10.1155/2012/862764. Epub 2012 Jun 7.
3
Investigation of Th1/Th2 cytokine profiles in patients with laryngo-pharyngeal, HPV-positive cancers.喉咽 HPV 阳性癌症患者 Th1/Th2 细胞因子谱的研究。
Eur Arch Otorhinolaryngol. 2013 Feb;270(2):711-8. doi: 10.1007/s00405-012-2067-7. Epub 2012 Jun 13.
4
Clinical utility of serum interleukin-8 and interferon-alpha in thyroid diseases.血清白细胞介素-8和干扰素-α在甲状腺疾病中的临床应用价值
J Thyroid Res. 2011 Mar 8;2011:270149. doi: 10.4061/2011/270149.
5
Role of serum interleukin-18 as a prognostic factor in patients with hepatocellular carcinoma.血清白细胞介素-18在肝细胞癌患者中作为预后因素的作用。
World J Gastroenterol. 2007 Aug 28;13(32):4345-9. doi: 10.3748/wjg.v13.i32.4345.
6
Enhanced induction of dendritic cell maturation and HLA-A*0201-restricted CEA-specific CD8(+) CTL response by exosomes derived from IL-18 gene-modified CEA-positive tumor cells.IL-18基因修饰的CEA阳性肿瘤细胞来源的外泌体增强树突状细胞成熟诱导及HLA-A*0201限制性CEA特异性CD8(+)CTL反应
J Mol Med (Berl). 2006 Dec;84(12):1067-76. doi: 10.1007/s00109-006-0102-0. Epub 2006 Sep 26.
7
Inflammatory gradient in Barrett's oesophagus: implications for disease complications.巴雷特食管的炎症梯度:对疾病并发症的影响。
Gut. 2002 Sep;51(3):316-22. doi: 10.1136/gut.51.3.316.
8
Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants.食管对胃食管反流的表型反应的多样性:免疫决定因素。
Gut. 2002 Apr;50(4):451-9. doi: 10.1136/gut.50.4.451.
9
Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect--a histopathological and immunohistochemical study.通过非特异性免疫反应预测直肠癌患者的局部和远处复发;特异性免疫反应仅具有全身效应——一项组织病理学和免疫组织化学研究。
BMC Cancer. 2001;1:7. doi: 10.1186/1471-2407-1-7. Epub 2001 Jul 16.
10
The pathogenesis of Barrett's esophagus: a process in continuum or discontinuum.巴雷特食管的发病机制:连续或不连续的过程。
Curr Gastroenterol Rep. 2000 Dec;2(6):421-4. doi: 10.1007/s11894-000-0001-4.